Back to search
Malignant Hematological Diseases
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Malignant Hematological Diseases trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Malignant Hematological Diseases trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This clinical trial evaluates the effect of expressive writing for the management of stress in cancer survivors. Cancer diagnosis and treatment are associated w…
The purpose of this study is to characterize the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary antitumor activity of EXS73565 admini…
This study investigates the changes in practice by pulmonary procedural programs across the United States as they faced the coronavirus pandemic. Information ga…
Return to work (RTW) of patients after cancer treatment has been a topic of growing interest for the past two decades. Advances in cancer care have led to bette…
This study collects information about complications and clinical response in cancer patients treated with anti-VEGF-related therapies. This study aims to observ…
This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing s…
Background: Clinical Genetics Branch (CGB) researchers study individuals and populations at high genetic risk of cancer in order to improve our understanding o…
This study will evaluate the safety, tolerability, and efficacy of Orca-T, an allogeneic stem cell and T-cell immunotherapy biologic manufactured for each patie…